2019
Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review
Ni Z, Dardas L, Wu B, Shaw R. Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review. Heart Asia 2019, 11: e011173. PMID: 31297162, PMCID: PMC6590990, DOI: 10.1136/heartasia-2018-011173.Peer-Reviewed Original ResearchCoronary heart diseaseCardioprotective medication adherenceMedication adherenceSystematic reviewPoor adherenceHeart diseaseSociodemographic characteristicsMedication-related knowledgeSecondary prevention guidelinesSecondary prevention medicationsPatients' sociodemographic characteristicsPoor medication adherencePatient medication adherenceAllied Health LiteratureHigh mortality rateHealth educational programsCardioprotective medicationsMedication characteristicsPrevention medicationsPrevention guidelinesPatient's perspectivePhysician perspectivesCumulative IndexReminder cardsMortality rate
2007
Older Patient Perspectives on Long-Term Anxiolytic Benzodiazepine Use and Discontinuation: A Qualitative Study
Cook JM, Biyanova T, Masci C, Coyne JC. Older Patient Perspectives on Long-Term Anxiolytic Benzodiazepine Use and Discontinuation: A Qualitative Study. Journal Of General Internal Medicine 2007, 22: 1094-1100. PMID: 17492325, PMCID: PMC2305752, DOI: 10.1007/s11606-007-0205-5.Peer-Reviewed Original ResearchConceptsChronic useBenzodiazepine useBenzodiazepine usersSemi-structured patient interviewsAcceptable intervention strategiesPrimary care physiciansOlder patients' perspectivesChronic benzodiazepine usersIntervention strategiesYears of ageImportance of preventionEarly intervention strategiesMedication characteristicsCare physiciansPatient factorsPatient interviewsParticipantsThe participantsPatient's perspectiveChronic usersSide effectsOrdinary medicationsDiscontinuationOlder adultsDesignThe designMedications
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply